Christopher R. Shubert

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response”.

Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4165

N/A

0DataRank · unranked

88 citations

Jacquelyn W. Zimmerman, Reecha Suri, Haley Zlomke, Gabriel D. Ivey, Annamária Szabolcs +17 more

Data from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response

(2023)10.1158/1078-0432.c.6532688

N/A

0DataRank · unranked

0 citations

Jacquelyn W. Zimmerman, Reecha Suri, Haley Zlomke, Gabriel D. Ivey, Annamária Szabolcs +17 more

Data from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response

(2023)10.1158/1078-0432.c.6532688.v1

N/A

0DataRank · unranked

0 citations

Jacquelyn W. Zimmerman, Reecha Suri, Haley Zlomke, Gabriel D. Ivey, Annamária Szabolcs +17 more

Sociodemographic variation in the utilization of minimally invasive surgical approaches for pancreatic cancer

HPB(2024)10.1016/j.hpb.2024.07.403

N/A

0DataRank · unranked

1 citations

Richard Zheng, Fabian M. Johnston, Jin He, William R. Burns, Christopher R. Shubert +3 more

The impact of a bloodless medicine program on pancreatic resections: A single-institution experience incorporating patients with borderline-resectable and locally advanced pancreatic cancer

Surgical Oncology Insight(2024)10.1016/j.soi.2024.100065

N/A

0DataRank · unranked

0 citations

Julia Purchla, N.C. Cruz, Ananda J. Thomas, Thomas McPhaul, Christopher R. Shubert +7 more

Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: an Analysis of 904 Patients with 7882 Person-Years of Follow-Up

Endocrine Pathology(2025)10.1007/s12022-025-09866-z

N/A

0DataRank · unranked

8 citations

Eric D. Young, Amanda L. Blackford, Pengfei Wu, Richard A. Burkhart, William R. Burns +14 more

Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-Up

medRxiv(2025)10.1101/2025.04.01.25325055

N/A

0DataRank · unranked

0 citations

Eric D. Young, Amanda L. Blackford, Pengfei Wu, Richard A. Burkhart, William R. Burns +14 more

The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinoma

Surgery(2025)10.1016/j.surg.2025.109611

N/A

0DataRank · unranked

0 citations

Joseph R. Habib, Benedict Kinny‐Köster, Julia Purchla, Jorge Franco, Aghnia J. Putri +16 more